Cytek Biosciences, Inc. - Common Stock - $0.001 par value (CTKB)

Historical Holders from Q3 2021 to Q3 2025

Symbol
CTKB on Nasdaq
Type / Class
Equity / Common Stock - $0.001 par value
Shares outstanding
127,940,509
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
79,957,176
Holdings value
$277,468,567
% of all portfolios
0.001%
Number of holders
151
Number of buys
79
Number of sells
-77
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Cytek Biosciences, Inc. - Common Stock - $0.001 par value (CTKB)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 13.1% -8.6% $56,208,317 -$6,633,186 16,531,858 -10.6% BlackRock, Inc. 30 Jun 2025
VANGUARD GROUP INC 6.13% -17.2% $26,401,469 -$6,313,358 7,765,138 -19.3% The Vanguard Group 30 Jun 2025
Topline Capital Management, LLC 5.3% $28,140,515 6,780,847 Topline Capital Management, LLC 25 Sep 2025
BROWN CAPITAL MANAGEMENT LLC 3.9% -33.2% $17,204,316 -$8,695,650 4,958,016 -33.6% Brown Capital Management, LLC 30 Sep 2025

Institutional Holders of Cytek Biosciences, Inc. - Common Stock - $0.001 par value (CTKB)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 79,957,176 $277,468,567 +$1,865,747 $3.47 151
2025 Q2 79,443,660 $270,126,999 +$5,595,600 $3.4 156
2025 Q1 77,562,435 $311,007,504 -$4,129,971 $4.01 159
2024 Q4 77,254,066 $501,381,338 +$11,940,410 $6.49 150
2024 Q3 74,960,438 $415,264,156 -$14,542,700 $5.54 134
2024 Q2 76,158,342 $424,969,676 -$33,289,478 $5.58 126
2024 Q1 80,524,601 $540,295,292 +$11,110,651 $6.71 119
2023 Q4 78,933,920 $719,883,797 +$17,961,713 $9.12 101
2023 Q3 77,486,686 $427,726,918 -$3,527,385 $5.52 106
2023 Q2 77,036,054 $657,934,234 +$69,958,551 $8.54 100
2023 Q1 68,508,151 $629,603,408 +$39,123,355 $9.19 100
2022 Q4 64,201,674 $655,512,030 +$29,671,547 $10.21 100
2022 Q3 61,170,760 $900,430,367 +$128,781,199 $14.72 87
2022 Q2 52,912,941 $567,776,021 +$56,303,644 $10.73 81
2022 Q1 47,712,980 $514,520,453 +$122,459,757 $10.78 72
2021 Q4 35,038,930 $571,924,873 -$4,872,187 $16.32 51
2021 Q3 34,351,929 $744,420,532 +$744,420,530 $21.41 53